John Ryan named senior vice president and general counsel at Dana-Farber

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

John Ryan was named senior vice president, general counsel and chief governance officer of Dana-Farber Cancer Institute.

Ryan began these roles Dec.1, 2020. Ryan has expertise representing health care and life sciences organizations in public company and non-profit settings. He has managed a range of legal matters, including medical research and technology, clinical care, IP protection and international expansion.

Ryan joins Dana-Farber from The Jackson Laboratory, where he was general counsel and corporate secretary. He previously held similar roles at Unilife Corp. and Aramark Corp., and was a partner at the Philadelphia-based law firm Duane Morris LLP.

Table of Contents

YOU MAY BE INTERESTED IN

Pfizer External Research & Grants’ “Improving Breast Cancer Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa,” powered by EveryGrant, has announced grants totaling more than $900,000 for addressing inequities and improving the quality of breast cancer care in Sub-Saharan Africa.
It started innocuously enough. I looked in the mirror and noticed a pigmented area on my scalp just into the hairline. Like many patients, thoughts started running through my head: “Maybe it’s nothing.” Looking at my Outlook calendar, it was packed morning-to-night with meetings, patients, and travel, so I decided I would get that spot checked out the minute I had “time.” 

In the morning of May 28, presumably before turning off the lights and closing the office door, someone at the now defunct NCI Office of Communications and Public Liaision decided to post a farewell message to the cancer community.  The message, posted on multiple social media accounts, read: We’re taking a pause here - but...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login